Accurate dosing of liquid medicines in children is crucial to ensure therapeutic efficacy and minimize adverse drug events. This review synthesizes current evidence on the accuracy of pediatric liquid medicine dose-measurement devices, examining epidemiology, pathophysiology, risk factors, clinical features, diagnostic challenges, and management strategies. Special emphasis is placed on recent advances, emerging technologies, and clinical guideline recommendations to optimize safe medication administration in pediatric patients. The article provides actionable insights for healthcare professionals to improve dosing accuracy and reduce medication errors in clinical practice.
Pediatric patients frequently require liquid medications due to developmental limitations in swallowing solid forms and the need for flexible dosing. However, dosing errors with liquid medicines remain a significant patient safety concern, often arising from inaccuracies in measurement devices such as oral syringes, dosing cups, droppers, and household spoons. These errors can lead to underdosing, therapeutic failure, or overdosing, resulting in toxicity and adverse outcomes. This review explores the evidence regarding the accuracy of various liquid medicine dose-measurement devices, the mechanisms underlying dosing errors, and their clinical implications in pediatric care.
Medication errors are among the most common preventable causes of harm in pediatric populations. Studies indicate that dosing errors account for over 40% of pediatric medication errors, with liquid formulations being particularly susceptible. Epidemiological data from multicenter studies in the United States and Europe reveal that between 60% and 80% of parents or caregivers make at least one dosing error when administering liquid medications to children. The consequences range from minor therapeutic inefficacy to severe toxicity, hospital admissions, and, rarely, fatalities. The burden is compounded in low-resource settings where standardized devices may be unavailable and health literacy is lower.
The pathophysiology of dosing errors in liquid medications is multifactorial. It is influenced by the design and calibration of measurement devices, the viscosity and surface tension of the liquid, and human factors such as visual acuity, manual dexterity, and cognitive understanding. Oral syringes generally provide higher accuracy due to precise calibration, but cups and spoons are more likely to be used incorrectly. Household spoons, in particular, are not standardized and can vary in volume by over 100%, leading to significant deviations from the intended dose. The risk of error is heightened in neonates and infants, where small errors can result in large relative dose discrepancies due to low body weight and immature metabolic pathways.
Several risk factors increase the likelihood of inaccurate dosing in pediatric liquid medications. These include low parental health literacy, language barriers, poor device labeling, suboptimal device design, and lack of standardized dosing instructions. Caregivers with limited numeracy or language proficiency are more likely to misinterpret dosing instructions. The presence of multiple dosing devices in the household can create confusion, especially if they are not matched to the specific product. Additionally, complex dosing regimens, such as those requiring weight-based calculations, further increase the risk of error.
The clinical manifestations of dosing inaccuracies are variable and depend on the medication involved, the dose deviation, and patient-specific factors. Underdosing may result in therapeutic failure, prolonged illness, or antimicrobial resistance in the case of antibiotics. Overdosing can cause toxicity, side effects, or acute poisoning. Signs of medication error-related toxicity may include gastrointestinal disturbances, neurological symptoms, cardiovascular instability, or metabolic derangements, necessitating prompt recognition and intervention.
Diagnosing medication errors related to inaccurate dosing devices often relies on a high index of suspicion. Clinicians should obtain a detailed medication history, including the type of device used, dosing instructions given, and caregiver understanding. Direct observation of dosing technique or review of device calibration can help identify potential sources of error. In cases of suspected overdose or underdose, laboratory investigations and drug level monitoring may be warranted, depending on the pharmacokinetics of the drug involved.
Management of dosing inaccuracies involves both acute interventions and preventive strategies. In cases of overdose, supportive care, activated charcoal, or specific antidotes may be indicated. For underdosing, prompt correction of the dose and monitoring for therapeutic response are key. Preventive measures include educating caregivers on proper dosing technique, providing standardized oral syringes with all liquid prescriptions, and ensuring clear, language-appropriate instructions. Pharmacists should demonstrate correct device use and verify caregiver understanding before dispensing liquid medications.
Recent advances in technology and device design have aimed to enhance dosing accuracy and reduce pediatric medication errors. Innovations include color-coded oral syringes, smart devices with digital dose readouts, and integrated safety features that prevent administration of incorrect volumes. Mobile applications and video tutorials are being developed to assist caregivers in proper dosing technique. Standardization initiatives, such as the "milliliter only" campaign, advocate for exclusive use of metric units to further minimize confusion and improve dosing precision.
Major health organizations, including the American Academy of Pediatrics (AAP) and the Institute for Safe Medication Practices (ISMP), recommend the use of oral syringes for all pediatric liquid medications, avoidance of household spoons, and provision of clear, standardized dosing instructions in milliliters. Guidelines emphasize the importance of health literacy assessment and tailored education for caregivers. Pharmacists and prescribers should collaborate to ensure dosing devices are matched to the prescribed volume, and that caregivers demonstrate competency prior to medication administration.
Accurate measurement of pediatric liquid medicines is a cornerstone of safe and effective care. Despite the availability of improved measurement devices, dosing errors remain prevalent due to a combination of device limitations, caregiver factors, and system-level challenges. Healthcare professionals must prioritize education, device standardization, and adherence to evidence-based guidelines to minimize the risk of error. Ongoing research and technological innovation hold promise for further enhancing dosing accuracy and patient safety in pediatric pharmacotherapy.
1.
Month-Long Wait Times Caused by US Physician Shortage.
2.
Talquetamab Regimens Boost Survival in Multiple Myeloma
3.
NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.
4.
Racial differences seen in epigenetic age acceleration in childhood cancer survivors
5.
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
1.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
2.
Automated Cell-Counter Calibration Using Reference Microbeads
3.
The Importance of Maintaining Normal Calcium Levels in Your Body
4.
The Power of Romiplostim in Treating Low Platelet Counts
5.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Thromboprophylaxis In Medical Settings
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Understanding the Common Causes of Anemia
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation